KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma

Contributed by: Business Wire

Tags

Biotechnology
Insurance
Pharmaceutical
Finance
Health
Asset Management
Infectious Diseases
Professional Services
KKR and Impilo Announce Strategic Partnership

More Like This

PR Newswire associated0

SPRIM Global Investments and OneIM Announce $300mn Joint Venture to Accelerate Clinical Trial Financing

Kyowa Kirin International and NewBridge Pharmaceuticals Enter Into Agreement to Improve Access to Medicines for Rare Disease Patients Across Middle East and North Africa

PR Newswire associated0

Norgine strengthens rare disease portfolio with acquisition of Theravia

Agillic joins partner Immeo in supporting the ‘Knæk Cancer’ (fight cancer) fundraising campaign

Seroba and Kurma Partners Announce Complementary Series B Funding for Vico Therapeutics totaling €65.8 million ($70.7 million)

KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma

Nordic Capital acquires majority share in IntegriChain, the only fully integrated platform for pharma commercialization and market access

Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges